Adaptin Bio

Adaptin Bio Inc. (OTCQB: APTN) is a clinical-stage biopharmaceutical company developing novel therapeutics targeting metabolic diseases including obesity, type 2 diabetes, and related conditions. According to adaptinbio.com, the company's pipeline focuses on peripheral mechanisms designed to reduce CNS-related side effects associated with older metabolic therapies.

Based in Charlotte, North Carolina, Adaptin Bio is led by a pharmaceutical development and regulatory team advancing its lead candidates through preclinical and early clinical stages. The company began trading on the OTCQB in April 2026 following completion of a merger transaction.

Adaptin Bio is building its clinical data package to support future regulatory filings. Full program information is available at adaptinbio.com.

Quick Links

Follow Us

Adaptin Bio

SEC Filings

Subscribe to our Newsletter

Get the latest alts news in your inbox every week.

Want your firm listed in our Alts Directory?

Send us your event information, and we'll promote it on our Events page!

Send us your job posting information, and we'll feature it on our Jobs page!

Send us your alts article or press release, and we'll post it on SQX Alts!

Tell us about your firm, and we'll reach out to set up a call.